Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin

Inhibition of the Nedd8 System Sensitizes Cells to DNA Interstrand Cross-linking Agents

(2012) Y. Kee et al.   MOLECULAR CANCER RESEARCH

SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype

(2011) Chantal Stoepker et al.   NATURE GENETICS

Mutations of the SLX4 gene in Fanconi anemia

(2011) Yonghwan Kim et al.   NATURE GENETICS

Expanded roles of the Fanconi anemia pathway in preserving genomic stability

(2010) Y. Kee et al.   GENES & DEVELOPMENT

New twists on proteasome inhibitors

(2010) Jim Kling   NATURE BIOTECHNOLOGY

Susceptibility Pathways in Fanconi's Anemia and Breast Cancer

(2010) Alan D. D'Andrea   NEW ENGLAND JOURNAL OF MEDICINE

Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics

(2010) Cynthia X. Ma et al.   TRENDS IN MOLECULAR MEDICINE

Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies

(2009) V. Raja Solomon et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

DNA interstrand crosslink repair in mammalian cells

(2009) Kevin M. McCabe et al.   JOURNAL OF CELLULAR PHYSIOLOGY

A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway

(2008) Igor Landais et al.   INTERNATIONAL JOURNAL OF CANCER

Cisplatin abrogates the geldanamycin-induced heat shock response

(2008) Andrea K. McCollum et al.   MOLECULAR CANCER THERAPEUTICS

Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

(2008) Wataru Sakai et al.   NATURE